These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Cytogenetic variants of dysregenerative and precancerous epithelial changes in chronic inflammatory pulmonary diseases]. Kogan EA; Paramonova NB; Demura SA; Popova EN Arkh Patol; 2003; 65(4):12-8. PubMed ID: 14518187 [TBL] [Abstract][Full Text] [Related]
4. [Expression of apoptosis and proliferation markers in progression of ovarian cancer]. Antoneeva II; Petrov SB Patol Fiziol Eksp Ter; 2008; (4):6-7. PubMed ID: 19198263 [TBL] [Abstract][Full Text] [Related]
5. Pathogenesis of bronchopulmonary dysplasia: the role of interleukin 1beta in the regulation of inflammation-mediated pulmonary retinoic acid pathways in transgenic mice. Bry K; Lappalainen U Semin Perinatol; 2006 Jun; 30(3):121-8. PubMed ID: 16813970 [TBL] [Abstract][Full Text] [Related]
10. Association of cell cycle-related gene products and NF-kappaB with clinical parameters in Langerhans cell histiocytosis. Amir G; Weintraub M Pediatr Blood Cancer; 2008 Feb; 50(2):304-7. PubMed ID: 17455317 [TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical expression of fatty acid synthase, apoptotic-regulating genes, proliferating factors, and ras protein product in colorectal adenomas, carcinomas, and adjacent nonneoplastic mucosa. Visca P; Alò PL; Del Nonno F; Botti C; Trombetta G; Marandino F; Filippi S; Di Tondo U; Donnorso RP Clin Cancer Res; 1999 Dec; 5(12):4111-8. PubMed ID: 10632348 [TBL] [Abstract][Full Text] [Related]
12. Correlation between histological type and immunohistochemical profile of prostate cancer and gleason scale gradation. Iemelynova AA; Grygorenko VM; Cheremuha SV; Romanenko AM Exp Oncol; 2009 Dec; 31(4):246-9. PubMed ID: 20010526 [TBL] [Abstract][Full Text] [Related]
13. Value of immunohistochemical markers in preinvasive bronchial lesions in risk assessment of lung cancer. Jeanmart M; Lantuejoul S; Fievet F; Moro D; Sturm N; Brambilla C; Brambilla E Clin Cancer Res; 2003 Jun; 9(6):2195-203. PubMed ID: 12796386 [TBL] [Abstract][Full Text] [Related]
14. Expression of apoptotic and cell proliferation regulatory proteins in actinic cheilitis. Martínez A; Brethauer U; Rojas IG; Spencer M; Mucientes F; Borlando J; Rudolph MI J Oral Pathol Med; 2005 May; 34(5):257-62. PubMed ID: 15817067 [TBL] [Abstract][Full Text] [Related]
15. A randomized phase IIb trial of pulmicort turbuhaler (budesonide) in people with dysplasia of the bronchial epithelium. Lam S; leRiche JC; McWilliams A; Macaulay C; Dyachkova Y; Szabo E; Mayo J; Schellenberg R; Coldman A; Hawk E; Gazdar A Clin Cancer Res; 2004 Oct; 10(19):6502-11. PubMed ID: 15475437 [TBL] [Abstract][Full Text] [Related]
16. The progression of morphologic changes in bronchopulmonary dysplasia. Erickson AM; de la Monte SM; Moore GW; Hutchins GM Am J Pathol; 1987 Jun; 127(3):474-84. PubMed ID: 3647732 [TBL] [Abstract][Full Text] [Related]
17. Pulmonary endostatin perinatally and in lung injury of the newborn infant. Janér J; Andersson S; Haglund C; Lassus P Pediatrics; 2007 Jan; 119(1):e241-6. PubMed ID: 17158946 [TBL] [Abstract][Full Text] [Related]
18. [Effect of different tidal volume ventilation on rat bronchial and alveolar epithelial cell apoptosis]. Hu GD; Cai SX; Chen YH; Gao F Di Yi Jun Yi Da Xue Xue Bao; 2005 May; 25(5):508-12. PubMed ID: 15897120 [TBL] [Abstract][Full Text] [Related]
19. Apoptotic markers p53, Bcl-2 and Bax in primary lung cancer. Porebska I; Wyrodek E; Kosacka M; Adamiak J; Jankowska R; Harłozińska-Szmyrka A In Vivo; 2006; 20(5):599-604. PubMed ID: 17091766 [TBL] [Abstract][Full Text] [Related]
20. Molecular marker profiles predict locoregional control of head and neck squamous cell carcinoma in a randomized trial of continuous hyperfractionated accelerated radiotherapy. Buffa FM; Bentzen SM; Daley FM; Dische S; Saunders MI; Richman PI; Wilson GD Clin Cancer Res; 2004 Jun; 10(11):3745-54. PubMed ID: 15173081 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]